NCT06775509

Brief Summary

Analyzing Optical Quality After the Use of Overnight Orthokeratology (Ortho-K)

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 11, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 15, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 15, 2025

Status Verified

January 1, 2025

Enrollment Period

8 months

First QC Date

December 11, 2024

Last Update Submit

January 8, 2025

Conditions

Keywords

Ortho-KOvernight OrthokeratologyProgression of MyopiaMyopiaAstigmatism

Outcome Measures

Primary Outcomes (1)

  • OPTICAL QUALITY

    The primary outcome measure is the change in total corneal higher-order aberrations between baseline and 30 days of orthokeratology lens wear. It will be expressed using Zernike coefficients in microns.

    1 month after using Ortho-K

Study Arms (1)

Ortho - k

EXPERIMENTAL

The Utilization of Otho-K Contact lenses

Device: Ortho-K

Interventions

Ortho-KDEVICE

Utilization of Ortho-K Contact Lenses for The Treatment of Myopia

Ortho - k

Eligibility Criteria

Age12 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients between 8 and 21 years old. Those who accept to participate in the study. The use of Ortho-K lenses for 8 to 10 hours per night, once the risks and benefits of using Ortho-K have been explained.
  • Refractive error of myopia between -1.00 and -5.00 diopters (D) with astigmatism of 1.50 D or less, with-the-rule.
  • Best-corrected visual acuity of 20/20 or better before treatment.
  • Ortho-K lens centered or decentered by no more than 0.5 mm radially, determined by slit-lamp examination.

You may not qualify if:

  • History of hard contact lens use and contraindications for ocular and systemic Ortho-K, determined by a routine examination.
  • Patients who have previously undergone any refractive modulation procedure.
  • Patients with any corneal pathology, dry eye, glaucoma, retinal pathology, strabismus, ptosis, amblyopia, history of ocular allergy, or infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Licari Vision

Tarragona, 43001, Spain

Location

MeSH Terms

Conditions

MyopiaAstigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Statistical Analysis
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophtalmologist Doctor

Study Record Dates

First Submitted

December 11, 2024

First Posted

January 15, 2025

Study Start

November 1, 2024

Primary Completion

July 1, 2025

Study Completion

December 31, 2025

Last Updated

January 15, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations